NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

患者自我調節注射器市場 - COVID-19影響與全球市場分析:至2027年的預測

Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product ; Application ; Distribution Channel, and Geography

出版商 The Insight Partners 商品編碼 983293
出版日期 內容資訊 英文 175 Pages
訂單完成後即時交付
價格
患者自我調節注射器市場 - COVID-19影響與全球市場分析:至2027年的預測 Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product ; Application ; Distribution Channel, and Geography
出版日期: 2020年11月27日內容資訊: 英文 175 Pages
簡介

全球患者自我調節注射器市場,從2019年的29億6,947萬美元,到2027年達到75億570萬美元,預計2020年∼2027年以12.4%的年複合成長率成長。

本報告提供全球患者自我調節注射器市場相關調查分析,市場形勢,市場動態,各市場區隔的市場分析,各地區的市場分析,競爭情形,主要企業相關的系統性資訊。

目錄

第1章 簡介

第2章 患者自我調節注射器市場:要點

第3章 調查手法

第4章 患者自我調節注射器市場:市場形勢

  • 概要
  • PEST分析
  • 專家的見解

第5章 患者自我調節注射器市場:主要的市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 未來趨勢
  • 影響分析

第6章 患者自我調節注射器市場:全球分析

  • 全球患者自我調節注射器市場收益預測與分析
  • 全球患者自我調節注射器市場:各地區 - 預測與分析
  • 主要企業的市場定位

第7章 患者自我調節注射器市場:各產品

  • 概要
  • 患者自我調節注射器市場佔有率:各產品
  • 電子
  • 機器
  • 輸液幫浦

第8章 患者自我調節注射器市場:各用途

  • 概要
  • 患者自我調節注射器市場佔有率:各用途
  • 癌症治療
  • 自體免疫疾病
  • 血液疾病治療
  • 其他

第9章 患者自我調節注射器市場:各流通管道

  • 概要
  • 患者自我調節注射器市場佔有率:各流通管道
  • 醫院藥局
  • 零售藥局
  • 郵購藥局

第10章 患者自我調節注射器市場:各地區分析

  • 北美:患者自我調節注射器市場
  • 歐洲:患者自我調節注射器市場
  • 亞太地區:患者自我調節注射器市場
  • 中東、非洲:患者自我調節注射器市場
  • 中南美:患者自我調節注射器市場

第11章 COVID-19對全球患者自我調節注射器市場的影響

  • 北美:COVID-19大流行的影響評估
  • 歐洲:COVID-19大流行的影響評估
  • 亞太地區:COVID-19大流行的影響評估
  • 中東、非洲:COVID-19大流行的影響評估
  • 中南美:COVID-19大流行的影響評估

第12章 患者自我調節注射器市場:產業形勢

  • 概要
  • 市場企業的成長策略
  • 有機的發展
  • 無機的發展

第13章 企業簡介

  • West Pharmaceutical Services, Inc.
  • Sensile Medical AG (Gerresheimer AG)
  • F. HOFFMANN-LA ROCHE LTD.
  • Johnson and Johnson Services, Inc.
  • Ypsomed AG
  • Westbourne Medical Limited
  • Enable Injections
  • scPharmaceuticals Inc.
  • United Therapeutics Corporation
  • BD

第14章 附錄

目錄
Product Code: TIPRE00015234

The patient controlled injectors market was valued at US$ 2,969.47 million in 2019 and is projected to reach US$ 7,505.70 million by 2027; it is expected to grow at a CAGR of 12.4% during 2020-2027. The growth of the patient controlled injectors market is mainly attributed to the factors such as increasing prevalence of chronic diseases and rising patient compliance. However, lack of adoption in emerging countries is likely to restraint the growth of the market during the forecast years.

Patient-controlled injectors are expected to rise concurrently in the market owing to greater ease, safety, and comfort of the administration of injections, which is likely to gain significant popularity among patients. Additionally, the controlled release of the patient-controlled injectors helps the patient administer the drug by themselves and decide their dosage rate.

Besides, the patient-controlled injectors can be administered at home settings, and thus, there is an increase in demand for patient-controlled injectors. Patient-controlled injectors present a strong solution for higher dosing volumes in non-clinical settings. Large volume of patient-controlled injectors are used for subcutaneous drug delivery at home care setting. Variants like these patient controlled self-administration devices are especially designed to administer highly viscous medications in large volumes. As per the WHO, ~2 million healthcare workers experience percutaneous exposure to infectious diseases each year. It further reveals that 37.6% of Hepatitis B and 4.4% of HIV/AIDS infections in healthcare workers are due to needle stick injuries worldwide. Many manufacturers are now focusing on developing patient-controlled injectors to meet the unmet needs, which, in turn, is stimulating the growth of the market. The easy administration of these drugs plays a crucial role in improving the compliance to drug therapies among patients, which drives patient outcomes. Considering these factors, the preference for controlled injectors, such as self-dose and Tremfya, is increasing among patients and healthcare providers. Besides, this self-injector is considered safe and efficacious among patients. For instance, according to a clinical trial report of July 2019, Guselkumab administered using the one-press patient controlled injector was very efficacious and well-tolerated in moderate-to-severe psoriasis patients. The researchers concluded that one-press controlled injector was highly acceptable over conventional drug delivery. Thus, unlike other drug delivery routes, this innovative route of administration does not require rigorous sterile methods for administering drugs into the body. Therefore, increasing preference for patient-controlled injectors among patients and health care providers, due to growing awareness regarding its benefits, is driving the market growth.

The demand for patient controlled injectors increased during the pandemic. Factors such as increased patient population, shortage of healthcare resources, and ease of increased the adoption of injectors had positive impact on the market by certain extent. However, implementation of physical distancing policies and total shut down of businesses in order to prevent the viral infection disrupted the supply chain operations, which caused a negative impact on the market growth.

Based on product, the patient controlled injectors market is segmented into electronic wearable injector, mechanical wearable injector, and infusion pumps. In 2019, the electronic wearable segment held the largest share of the market, whereas, the mechanical wearable injector segment is projected to register the highest CAGR in the market during the forecast period.

Based on application, the patient controlled injectors market is segmented into cancer treatment, auto-immune treatment, blood disorders treatment, and others. The cancer treatment segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.

Based on distribution channel, the patient controlled injectors market is segmented into hospital pharmacies, retail pharmacies, and mail order pharmacies. The hospital pharmacies segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.

The World Health Organization (WHO), Food and Drug Administration (FDA), NHS (National Health Service), and Centers for Disease Control and Prevention are among the major primary and secondary sources referred for preparing this report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the patient controlled injectors market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global patient controlled injectors market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Patient Controlled Injectors Market - By Product
    • 1.3.2 Global Patient Controlled Injectors Market - By Application
    • 1.3.3 Global Patient Controlled Injectors Market - By Distribution Channel
    • 1.3.4 Global Patient Controlled Injectors Market - By Geography

2. Patient Controlled Injectors Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Patient Controlled Injectors Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East & Africa- PEST Analysis
    • 4.2.5 South & Central America - PEST Analysis
  • 4.3 Expert Opinion

5. Patient Controlled Injectors Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Rising Patient Compliance
  • 5.2 Market Restraints
    • 5.2.1 Lack of Adoption in Emerging Countries
  • 5.3 Market Opportunities
    • 5.3.1 Technological Advancements and Design Development
  • 5.4 Future Trends
    • 5.4.1 Consolidation of Market
  • 5.5 Impact Analysis

6. Patient Controlled Injectors Market - Global Analysis

  • 6.1 Global Patient Controlled Injectors Market Revenue Forecast and Analysis
  • 6.2 Global Patient Controlled Injectors Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Patient Controlled Injectors Market- By Product

  • 7.1 Overview
  • 7.2 Patient Controlled Injectors Market Share, by Product, 2019 and 2027 (%)
  • 7.3 Electronic Injectors
    • 7.3.1 Overview
    • 7.3.2 Electronic Injectors: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • 7.4 Mechanical Injectors
    • 7.4.1 Overview
    • 7.4.2 Mechanical Injectors: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • 7.5 Infusion Pumps
    • 7.5.1 Overview
    • 7.5.2 Infusion Pumps: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)

8. Patient Controlled Injectors Market- By Application

  • 8.1 Overview
  • 8.2 Patient Controlled Injectors Market Share, by Application, 2019 and 2027 (%)
  • 8.3 Cancer Treatment
    • 8.3.1 Overview
    • 8.3.2 Cancer Treatment: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • 8.4 Autoimmune Disease
    • 8.4.1 Overview
    • 8.4.2 Autoimmune Disease: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • 8.5 Blood Disorders Treatment
    • 8.5.1 Overview
    • 8.5.2 Blood Disorder Treatment: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)

9. Patient Controlled Injectors Market- By Distribution Channel

  • 9.1 Overview
  • 9.2 Patient Controlled Injectors Market Share, by Distribution Channel, 2019 and 2027 (%)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • 9.4 Retail Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Retail Pharmacies: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • 9.5 Mail Order Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Mail Order Pharmacies: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)

10. Patient Controlled Injectors Market - Geographic Analysis

  • 10.1 North America: Patient Controlled Injectors Market
    • 10.1.1 Overview
    • 10.1.2 North America: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America Patient Controlled Injectors Market, by Product- Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 North America Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
    • 10.1.5 North America Patient Controlled Injectors Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 North America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US Patient Controlled Injectors Market, by Product- Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 US Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.1.7.4 US Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 Canada: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada Patient Controlled Injectors Market, by Products - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 Canada Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.1.8.4 Canada Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.1.9 Mexico: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico Patient Controlled Injectors Market, by Products - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.3 Mexico Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.1.9.4 Mexico Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.2 Europe: Patient Controlled Injectors Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
    • 10.2.3 Europe Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.2.4 Europe Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
    • 10.2.5 Europe Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.6 Europe: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
    • 10.2.7 Germany: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.1 Germany: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.2 Germany Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.3 Germany Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.2.7.4 Germany Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.8 UK: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.1 UK: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.2 UK Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.3 UK Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.2.8.4 UK Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.9 France: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.1 France: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.2 France Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.3 France Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.2.9.4 France Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.10 Spain: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.1 Spain: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.2 Spain Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.3 Spain Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.2.10.4 Spain Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.11 Italy: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.1 Italy: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.2 Italy Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.3 Italy Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.2.11.4 Italy Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.2.12 Rest of Europe
      • 10.2.12.1 Rest of Europe Patient Controlled Injectors Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.2.12.2 Rest of Europe Patient Controlled Injectors Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.2.12.3 Rest of Europe Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
      • 10.2.12.4 Rest of Europe Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.3 Asia Pacific: Patient Controlled Injectors Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
    • 10.3.3 Asia Pacific Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.3.4 Asia Pacific Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
    • 10.3.5 Asia Pacific Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.6 Asia Pacific: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
    • 10.3.7 China: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.1 China: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.2 China Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.3 China Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.3.7.4 China Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.8 Japan: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.1 Japan: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.2 Japan Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.3 Japan Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.3.8.4 Japan Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.9 India: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.1 India: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.2 India Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.3 India Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.3.9.4 India Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.10 South Korea: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.1 South Korea: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.2 South Korea Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.3 South Korea Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.3.10.4 South Korea Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.11 Australia: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.1 Australia: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.2 Australia Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.3 Australia Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.3.11.4 Australia Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.3.12 Rest of Asia Pacific: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.1 Rest of Asia Pacific: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.2 Rest of Asia Pacific Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.3 Rest of Asia Pacific Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
      • 10.3.12.4 Rest of Asia Pacific Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.4 Middle East & Africa: Patient Controlled Injectors Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (US$ Million)
    • 10.4.3 Middle East & Africa Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.4.4 Middle East & Africa Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
    • 10.4.5 Middle East & Africa Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.6 Middle East & Africa: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
    • 10.4.7 UAE: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.1 UAE: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.2 UAE Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.3 UAE Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.4.7.4 UAE Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.8 Saudi Arabia: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.1 Saudi Arabia: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.2 Saudi Arabia Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.3 Saudi Arabia Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.4.8.4 Saudi Arabia Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.9 South Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.1 South Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.2 South Africa Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.3 South Africa Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.4.9.4 South Africa Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.4.10 Rest of Middle East and Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.1 Rest of Middle East and Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.2 Rest of Middle East and Africa Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.3 Rest of Middle East and Africa Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.4.10.4 Rest of Middle East and Africa Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 10.5 South and Central America: Patient Controlled Injectors Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
    • 10.5.3 South and Central America Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.5.4 South and Central America Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
    • 10.5.5 South and Central America Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.5.6 South and Central America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
    • 10.5.7 Brazil: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.1 Brazil: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.2 Brazil Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.3 Brazil Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.5.7.4 Brazil Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.5.8 Argentina: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.1 Argentina: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.2 Argentina Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.3 Argentina Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.5.8.4 Argentina Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 10.5.9 Rest of South and Central America: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.1 Rest of South and Central America: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.2 Rest of South and Central America Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.5.9.3 Rest of South and Central America Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.5.9.4 Rest of South and Central America Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)

11. Impact Of COVID-19 Pandemic on Global Patient Controlled Injectors Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment Of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Patient Controlled Injectors Market -Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 West Pharmaceutical Services, Inc.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Sensile Medical AG (Gerresheimer AG)
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 F. HOFFMANN-LA ROCHE LTD.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Johnson and Johnson Services, Inc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Ypsomed AG
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Westbourne Medical Limited
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Enable Injections
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 scPharmaceuticals Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 United Therapeutics Corporation
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 BD
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 3. North America Patient Controlled Injectors Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
  • Table 4. US Patient Controlled Injectors Market, by Product- Revenue and Forecast to 2027 (USD Million)
  • Table 5. US Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 6. US Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Canada Patient Controlled Injectors Market, by Products - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Canada Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 9. Canada Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Mexico Patient Controlled Injectors Market, by Products - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Mexico Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 12. Mexico Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Europe Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Europe Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 15. Europe Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Germany Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Germany Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 18. Germany Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 19. UK Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 20. UK Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 21. UK Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Incidence, Mortality and Prevalence by cancer site, 2018, France
  • Table 23. France Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 24. France Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 25. France Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Spain Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Spain Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 28. Spain Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 29. Incidence, Mortality and Prevalence by cancer site, 2018, Italy
  • Table 30. Italy Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 31. Italy Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 32. Italy Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Rest of Europe Patient Controlled Injectors Market Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 34. Rest of Europe Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 35. Rest of Europe Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 36. Asia Pacific Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Asia Pacific Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 38. Asia Pacific Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 39. China Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 40. China Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 41. China Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 42. Japan Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 43. Japan Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 44. Japan Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 45. India Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 46. India Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 47. India Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 48. South Korea Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 49. South Korea Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 50. South Korea Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 51. Australia Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 52. Australia Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 53. Australia Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 54. Rest of Asia Pacific Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 55. Rest of Asia Pacific Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 56. Rest of Asia Pacific Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 57. Middle East & Africa Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 58. Middle East & Africa Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 59. Middle East & Africa Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 60. UAE Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 61. UAE Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 62. UAE Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 63. Saudi Arabia Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 64. Saudi Arabia Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 65. Saudi Arabia Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 66. South Africa Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 67. South Africa Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 68. South Africa Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Rest of Middle East and Africa Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Rest of Middle East and Africa Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 71. Rest of Middle East and Africa Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 72. South and Central America Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 73. South and Central America Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 74. South and Central America Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 75. Brazil Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 76. Brazil Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 77. Brazil Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 78. Argentina Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 79. Argentina Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 80. Argentina Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 81. Rest of South and Central America Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 82. Rest of South and Central America Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 83. Rest of South and Central America Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 84. Organic Developments Done By Companies
  • Table 85. Inorganic Developments Done By Companies
  • Table 86. Glossary of Terms, Patient Controlled Injectors Market

List Of Figures

  • Figure 1. Patient Controlled Injectors Market Segmentation
  • Figure 2. Patient Controlled Injectors Segmentation, By Region
  • Figure 3. Global Patient Controlled Injectors Market Overview
  • Figure 4. Electronic Wearable Injector Segment Held Largest Share of Patient Controlled Injectors Market
  • Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
  • Figure 6. Patient Controlled Injectors Market, by Geography (US$ Million)
  • Figure 7. Global Patient Controlled Injectors Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Patient Controlled Injectors Market, Industry Landscape
  • Figure 9. North America : PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East & Africa PEST Analysis
  • Figure 13. South & Central America PEST Analysis
  • Figure 14. Patient Controlled Injectors Market Impact Analysis of Driver and Restraints
  • Figure 15. Global Patient Controlled Injectors Market - Revenue Forecast and Analysis - 2019- 2027
  • Figure 16. Global Patient Controlled Injectors Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global Patient Controlled Injectors Market
  • Figure 18. Patient Controlled Injectors Market Share, by Product, 2019 and 2027 (%)
  • Figure 19. Electronic Injectors: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 20. Mechanical Injectors: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 21. Infusion Pumps: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 22. Patient Controlled Injectors Market Share, by Application, 2019 and 2027 (%)
  • Figure 23. Cancer Treatment: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 24. Autoimmune Disease: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 25. Blood Disorder Treatment: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 26. Others: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 27. Patient Controlled Injectors Market Share, by End user, 2019 and 2027 (%)
  • Figure 28. Hospital Pharmacies: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 29. Retail Pharmacies: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 30. Mail Order Pharmacies: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 31. North America: Patient Controlled Injectors Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 32. North America Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
  • Figure 33. North America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
  • Figure 34. US: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 35. Canada: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 36. Mexico: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 37. Europe: Patient Controlled Injectors Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 38. Europe Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
  • Figure 39. Europe: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
  • Figure 40. Germany: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 41. UK: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 42. France: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 43. Spain: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Italy: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. Rest of Europe Patient Controlled Injectors Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 46. Asia Pacific: Patient Controlled Injectors Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 47. Asia Pacific Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
  • Figure 48. Asia Pacific: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
  • Figure 49. China: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. Japan: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. India: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. South Korea: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Australia: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. Rest of Asia Pacific: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. Middle East & Africa: Patient Controlled Injectors Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 56. Middle East & Africa Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
  • Figure 57. Middle East & Africa: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
  • Figure 58. UAE: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. Saudi Arabia: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 60. South Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 61. Rest of Middle East and Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 62. South and Central America: Patient Controlled Injectors Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 63. South and Central America Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
  • Figure 64. South and Central America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
  • Figure 65. Brazil: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 66. Argentina: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 67. Rest of South and Central America: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 68. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 69. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 70. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 71. Impact Of COVID-19 Pandemic in Middle East and Africa Market
  • Figure 72. Impact Of COVID-19 Pandemic in South and Central America Market
  • Figure 73. Growth Strategies Done by the Companies in the Market, (%)